--- title: New Zealand Approves ‘Shrooms’ to Treat Depression description: New Zealand is the latest government to approve the therapeutic use of psilocybin, a known hallucinogen. canonical: https://time.com/7295413/psilocybin-magic-mushrooms-hallucinogen-new-zealand-approved-medicinal-therapeutic-depression/ author: Chad de Guzman article:opinion: false article:content_tier: free article:published_time: 2025-06-18T09:45:00.000Z article:modified_time: 2026-03-11T00:55:43.309Z article:section: Health og:title: New Zealand Approves ‘Shrooms’ to Treat Depression og:description: New Zealand is the latest government to approve the therapeutic use of psilocybin, a known hallucinogen. og:url: https://time.com/7295413/psilocybin-magic-mushrooms-hallucinogen-new-zealand-approved-medicinal-therapeutic-depression/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt0ab3a4733a79a4fc/6998c79a83ec3750cac7ab22/magic-mushrooms-shrooms-medicinal-use.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 og:image:width: 1024 og:image:height: 576 og:image:alt: Psilocybin Mushrooms Increasingly Sought For Therapeutic Purposes og:type: article twitter:card: summary_large_image twitter:title: New Zealand Approves ‘Shrooms’ to Treat Depression twitter:description: New Zealand is the latest government to approve the therapeutic use of psilocybin, a known hallucinogen. twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt0ab3a4733a79a4fc/6998c79a83ec3750cac7ab22/magic-mushrooms-shrooms-medicinal-use.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 ---  # New Zealand Becomes Latest Government to Approve ‘Shrooms’ for Medicinal Use > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: September 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=af1a28bf-8218-4509-8dd0-6aecb86c4460&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | | Health Matters | The latest health news and expert advice on living well | Weekdays | | Worth Your Time | A weekly guide to what to watch, read, and more | Weekly | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Twice a week | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | Source: TIME, August 2026. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=af1a28bf-8218-4509-8dd0-6aecb86c4460&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=af1a28bf-8218-4509-8dd0-6aecb86c4460&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement. ### Sources * TIME Newsletters: [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=af1a28bf-8218-4509-8dd0-6aecb86c4460&cr=time-nl-network-2026q3-v1)  by [Chad de Guzman](https://time.com/author/chad-de-guzman/)  ## Chad de Guzman Reporter Jun 18, 2025 9:45 AM UTC  Psilocybin mushrooms grow in a humidified monotub in the basement of a private home in Fairfield County, Conn., in 2023. Psilocybin mushrooms grow in a humidified monotub in the basement of a private home in Fairfield County, Conn., in 2023. John Moore—Getty Images  by [Chad de Guzman](https://time.com/author/chad-de-guzman/)  ## Chad de Guzman Reporter Jun 18, 2025 9:45 AM UTC Psilocybin—a notorious hallucinogen found in “[magic mushrooms](https://time.com/7032706/are-mushroom-edibles-safe-legal/)”—is a federally controlled substance that the U.S. deems to have “no currently accepted medical use” and “a high potential for abuse.” But not everyone agrees with that assessment: New Zealand on Wednesday became the latest country to approve the use of the substance for therapeutic purposes. David Seymour, New Zealand’s Associate Minister for Health, told reporters that [the new policy](https://www.beehive.govt.nz/release/government-expands-access-melatonin-and-psilocybin), which allows a single approved psychiatrist to prescribe psilocybin to patients with treatment-resistant depression, represents a “[real breakthrough](https://www.rnz.co.nz/news/political/564504/melatonin-to-be-sold-over-the-counter-psilocybin-to-be-prescribed).” Seymour said that the psychiatrist, [identified as Cameron Lacey](https://www.nzherald.co.nz/nz/meet-the-one-psychiatrist-approved-to-prescribe-magic-mushrooms-in-new-zealand/GIM2JVVV2FEKTCYFAKVNX2P7WY/), a [professor at the University of Otago](https://www.otago.ac.nz/healthsciences/expertise/profile?id=586), “has previously prescribed psilocybin in clinical trials and will operate under strict reporting and record-keeping requirements.” Seymour added that he is hoping more psychiatrists will apply for clearance to prescribe the drug to patients, though he clarified that the drug remains “unapproved medicine.” At the same time as the psilocybin policy change was announced, New Zealand announced plans to loosen restrictions on melatonin, which is used to treat insomnia and is sold over the counter in many other places. As Seymour promised to expand access to treatments like melatonin and psilocybin, no specific date was set for when they will be available across the country. ## Where is the use of psilocybin for medicinal purposes legal? New Zealand is not alone in permitting the medicinal use of the drug. Australia, in July 2023, [authorized](https://www.tga.gov.au/news/media-releases/change-classification-psilocybin-and-mdma-enable-prescribing-authorised-psychiatrists) specific psychiatrists to prescribe it for the treatment of certain mental health conditions. In Switzerland, using LSD, MDMA, and psilocybin in medicine [has been legal](https://www.swissinfo.ch/eng/multinational-companies/switzerland-is-home-to-europes-only-psychedelics-treatment/89195943) since 2014, for both research and treatment of mental health conditions. And while the substance is generally illegal in Canada, regulated [medical use](https://www.canada.ca/en/health-canada/services/substance-use/controlled-illegal-drugs/magic-mushrooms.html) is allowed under strict conditions. Even some states in the U.S. have allowed some degree of use. Oregon became the first state to legalize psilocybin’s therapeutic use in 2020, though some cities have banned the drug. Still, in the state, access to the drug remains restricted: it may only be administered in a [licensed psilocybin service center](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/Documents/OPS-Fact-Sheet.pdf), and an administration session can cost up to $2,000, according to the [Associated Press](https://apnews.com/article/oregon-psilocybin-psychedelic-mushrooms-ban-9c73a25986171b41bb162100d54d2217). Colorado also [legalized](https://www.pbs.org/newshour/health/colorado-veterans-and-conservatives-clash-over-psychedelic-therapy) the regulated use of psilocybin for medical use in a ballot measure in 2022, with the first licenses for dispensing it issued [earlier this year.](https://abcnews.go.com/Health/colorado-psychedelic-mushroom-experiment-arrived/story?id=120109227) And in April, New Mexico [legalized](https://www.nmlegis.gov/Sessions/25%20Regular/bills/senate/SB0219.HTML) psilocybin’s use in approved settings to treat certain medical conditions. Laws on the regulated medical use of psilocybin are also making their way through state legislatures like [Minnesota](https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF2906&ssn=0&y=2025) and [Massachusetts](https://malegislature.gov/Bills/194/HD3368). [Said](https://www.beehive.govt.nz/release/government-expands-access-melatonin-and-psilocybin) Seymour in announcing New Zealand’s rationale for changing its tune on the drug: “If a doctor believes psilocybin can help, they should have the tools to try.” ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/7295413/psilocybin-magic-mushrooms-hallucinogen-new-zealand-approved-medicinal-therapeutic-depression/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/7295413/psilocybin-magic-mushrooms-hallucinogen-new-zealand-approved-medicinal-therapeutic-depression/"},"headline":"New Zealand Becomes Latest Government to Approve ‘Shrooms’ for Medicinal Use","datePublished":"2025-06-18T09:45:00.000Z","dateModified":"2026-03-11T00:55:43.309Z","description":"New Zealand is the latest government to approve the therapeutic use of psilocybin, a known hallucinogen.","url":"https://time.com/7295413/psilocybin-magic-mushrooms-hallucinogen-new-zealand-approved-medicinal-therapeutic-depression/","keywords":["Drugs","overnight","News Desk"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt0ab3a4733a79a4fc/6998c79a83ec3750cac7ab22/magic-mushrooms-shrooms-medicinal-use.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Chad de Guzman","jobTitle":"Reporter","url":"https://time.com/author/chad-de-guzman/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt0ab3a4733a79a4fc/6998c79a83ec3750cac7ab22/magic-mushrooms-shrooms-medicinal-use.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"Psilocybin Mushrooms Increasingly Sought For Therapeutic Purposes","caption":"Psilocybin Mushrooms Increasingly Sought For Therapeutic Purposes","creditText":"John Moore—Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/drugs/","name":"Drugs"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/7295413/psilocybin-magic-mushrooms-hallucinogen-new-zealand-approved-medicinal-therapeutic-depression/","name":"New Zealand Becomes Latest Government to Approve ‘Shrooms’ for Medicinal Use"}}]}] ```